X-ray computed tomography imaging of a tumor with high sensitivity using gold nanoparticles conjugated to a cancer-specific antibody via polyethylene glycol chains on their surface

References

• Kalender WA. X-ray computed tomography. Phys Med Biol. 2006;51:20.
   Web of Science ®Google Scholar
• Mattrey RF, Aguirre DA. Advances in contrast media research. Acad Radiol. 2003;10:1450–1460.
   PubMed Web of Science ®Google Scholar
• Clough RE, Hussain T, Uribe S, et al. A new method for quantification of false lumen thrombosis in aortic dissection using magnetic resonance imaging and a blood pool contrast agent. J Vasc Surg. 2011;54:1251–1258.
   PubMed Web of Science ®Google Scholar
• Jaspers K, Versluis B, Leiner T, et al.MR angiography of collateral arteries in a hind limb ischemia model: comparison between blood pool agent Gadomer and small contrast agent Gd-DTPA. PLoS One. 2011;6:0016159.
   Web of Science ®Google Scholar
• Liu Y, Ai K, Lu L. Nanoparticulate X-ray computed tomography contrast agents: from design validation to in vivo applications. Acc Chem Res. 2012;45:1817–1827.
   PubMed Web of Science ®Google Scholar
• He W, Ai K, Lu L. Nanoparticulate X-ray CT contrast agents. Sci China Chem. 2015;58:753–760.
   Web of Science ®Google Scholar
• De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJAM, Geertsma RE. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials. 2008;29:1912–1919.
   PubMed Web of Science ®Google Scholar
• He C, Hu Y, Yin L, Tang C, Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010;31:3657–3766.
   PubMed Web of Science ®Google Scholar
• Braet F, Wisse E. Structural and functional aspects of liver sinosoidal endothelial cell fenestrae. Comp hepatol. 2002;1.
   PubMedGoogle Scholar
• Risau W. Differentiation of endothelium. Faseb J. 1995;9:926–933.
   PubMed Web of Science ®Google Scholar
• Wisse E, Jacobs F, Topal B, Frederik P, De Geest B. The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer. Gene Ther. 2008;15:1193–1199.
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. A New concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986;46:6387–6392.
   PubMed Web of Science ®Google Scholar
• Hara T, Iriyama S, Makino K, Terada H, Ohya M. Mathematical description of drug movement into tumor with EPR effect and estimation of its configuration for DDS. Colloids Surf B Biointerfaces. 2010;75:42–46.
   PubMed Web of Science ®Google Scholar
• Acharya S, Sahoo SK. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev. 2011;63:170–183.
   PubMed Web of Science ®Google Scholar
• Sakurai Y, Tada H, Gonda K, et al. Development of silica-coated silver iodide nanoparticles and their biodistribution. Tohoku J Exp Med. 2012;228:317–323.
   PubMed Web of Science ®Google Scholar
• Rabin O, ManuelPerez J, Grimm J, Wojtkiewicz G, Weissleder R. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater. 2006;5:118–122.
   PubMed Web of Science ®Google Scholar
• Hainfeld JF, Dilmanian FA, Slatkin DN, Smilowitz HM. Radiotherapy enhancement with gold nanoparticles. J Pharm Pharmacol. 2008;60:977–985.
   PubMed Web of Science ®Google Scholar
• O’Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 2004;209:171–176.
   PubMed Web of Science ®Google Scholar
• Cai W, Gao T, Hong H, Sun J. Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol Sci Appl. 2008;1:17–32.
   PubMedGoogle Scholar
• Hawley AE, Illum L, Davis SS. Preparation of biodegradable surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake. Pharm Res. 1997;14:657.
   PubMed Web of Science ®Google Scholar
• Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Science. 1994;263:1600–1603.
   PubMed Web of Science ®Google Scholar
• Li S-D, Huang L. Pharmacokinetics and Biodistribution of Nanoparticles. Mol Pharm. 2008;5:496–504.
   PubMed Web of Science ®Google Scholar
• Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev. 2009;61:428–437.
   PubMed Web of Science ®Google Scholar
• Niidome T, Yamagata M, Okamoto Y, et al. PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release. 2006;114:343–347.
   PubMed Web of Science ®Google Scholar
• Vogel CL, Cobleigh MA, Tripathy D, et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol. 2002;20:719–726.
   PubMed Web of Science ®Google Scholar
• van Schooneveld MM, Cormode DP, Koole R, et al. A fluorescent, paramagnetic and PEGylated gold/silica nanoparticle for MRI, CT and fluorescence imaging. Contrast Media Mol Imaging. 2010;5:231–236.
   PubMed Web of Science ®Google Scholar
• Cai QY, Kim SH, Choi KS, et al. Colloidal gold nanoparticles as a blood-pool contrast agent for X-ray computed tomography in mice. Invest Radiol. 2007;42:797–806.
   PubMed Web of Science ®Google Scholar
• Kurebayashi J, Otsuki T, Tang CK, et al. Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6. Br J Cancer. 1999;79:707–717.
   PubMed Web of Science ®Google Scholar
• Lu Y, Chen Y, Gemeinhart RA, Wu W, Li T. Developing nanocrystals for cancer treatment. Nanomedicine. 2015;10:2537–2552.
   PubMed Web of Science ®Google Scholar
• Wang H, Yu J, Lu X, He X. Nanoparticle systems reduce systemic toxicity in cancer treatment. Nanomedicine. 2016;11:103–106.
   PubMed Web of Science ®Google Scholar
• Meng H, Xue M, Xia T, et al. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. ACS Nano. 2011;5:4131–4144.
   PubMed Web of Science ®Google Scholar
• Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol. 2004;49:N309–315.
   PubMed Web of Science ®Google Scholar
• Kim D, Park S, Lee JH, Jeong YY, Jon S. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc. 2007;129:7661–7665.
   PubMed Web of Science ®Google Scholar